Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors
Author Information
Author(s): Kulke Matthew H, Bendell Johanna, Kvols Larry, Picus Joel, Pommier Rodney, Yao James
Primary Institution: Dana-Farber Cancer Institute
Conclusion
Recent studies have shown that treatments like sunitinib and everolimus can improve progression-free survival in patients with advanced pancreatic neuroendocrine tumors.
Supporting Evidence
- Patients with pancreatic neuroendocrine tumors often present with diverse symptoms.
- Surgical resection is the main treatment for localized disease.
- Recent studies have shown that sunitinib improves progression-free survival in patients with advanced pancreatic NET.
Takeaway
Pancreatic neuroendocrine tumors can cause different symptoms, and there are various ways to diagnose and treat them, including surgery and medications.
Methodology
The study reviews various diagnostic and treatment strategies for pancreatic neuroendocrine tumors, including imaging, surgical management, and systemic therapies.
Potential Biases
Potential conflicts of interest due to authors' consulting roles with pharmaceutical companies.
Limitations
The study may not cover all potential treatment options or patient demographics.
Participant Demographics
Patients with pancreatic neuroendocrine tumors, including those with advanced disease.
Statistical Information
P-Value
0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website